HIGHLIGHTS
- What: The aim of this study was to evaluate the safety and efficacy of the p64 classic FDS, p48 MW HPC FDS, and p64 MW HPC FDS (all from WallabyPhenox, GmbH, Bochum, Germany) in terms of ischemic complications and occlusion rates, and to identify factors predicting and preventing treatment failure.
- Who: V. Hellstern from the University of Missouri System, United States have published the Article: Flow diversion for unruptured MCA bifurcation aneurysms: comparison of p64 classic, p64 MW HPC, and p48 MW HPC flow diverter stents, in the Journal: (JOURNAL)
- How: Before the . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.